CELEX: 62021TN0146
Language: en
Date: 2021-03-15 00:00:00
Title: Case T-146/21: Action brought on 15 March 2021 — Vetpharma Animal Health v EUIPO — Deltavit (DELTATIC)

10.5.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 182/61
            
         
      Action brought on 15 March 2021 — Vetpharma Animal Health v EUIPO — Deltavit (DELTATIC)
      (Case T-146/21)
      (2021/C 182/83)
      Language of the case: English
      
         Parties
      
      
         Applicant: Vetpharma Animal Health, SL (Barcelona, Spain) (represented by: M. Escudero Pérez, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Deltavit SAS (Janzé, France)
      
         Details of the proceedings before EUIPO
      
      
         Applicant of the trade mark at issue: Applicant before the General Court
      
         Trade mark at issue: Application for European Union word mark DELTATIC — Application for registration No 17 806 241
      
         Procedure before EUIPO: Opposition proceedings
      
         Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 21 December 2020 in Case R 776/2020-5
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision;
               
            
                  —
               
               
                  order EUIPO and the other party to bear their own costs and to pay those of the applicant.
               
            
         Pleas in law
      
      
                  —
               
               
                  Infringement of Article 47(2) in connection with Article 18(1), second subparagraph, point a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;
               
            
                  —
               
               
                  Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.